ArticleInternational journal of hematology2025

Synergistic effect of asciminib with reduced doses of ponatinib in human Ph + myeloid leukemia with the T315M mutation.

Thao Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.